Chemcon Speciality Chemicals Ltd · NSE:CHEMCON
Chemcon Speciality Chemicals — Investor Presentation (August 2024)
27 slides from Chemcon Speciality Chemicals's investor presentation, Aug 5, 2024
Slide 1: Cover letter to stock exchanges
August 5, 2024 To, To, BSE Limited National Stock Exchange of India Limited Listing Compliance & Legal Regulatory Listing & Compliance Phiroze Jeejeebhoy Towers, Exchange Plaza, Bandra-Kurla Complex, Dalal Street, Mumbai - 400 001 Bandra East, Mumbai 400 051 Stock Code: 543233 Stock Symbol: CHEMCON
Slide 2: Chemcon Speciality Chemicals Limited Investor Presentation – August 2024
Chemcon Speciality Chemicals Limited Investor Presentation – August 2024
Slide 3: Safe Harbor
Safe Harbor This presentation and the accompanying slides (the “Presentation”), which have been prepared by Chemcon Speciality Chemicals Limited (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe
Slide 4: Q1 FY25 Performance Highlights
Q1 FY25 Performance Highlights
Slide 5: Q1 FY25 Performance Highlights
Q1 FY25 Performance Highlights “We have registered a total revenue of Rs 45 crores for Q1FY25, a significant drop on a YoY basis led by substantial drop in Inorganic Chemicals business. Inorganic chemicals segment has faced challenges due to supply chain disruptions, demand softening, and lower real
Slide 6: Financial Highlights
Financial Highlights Total Revenue (Rs. Cr) EBITDA (Rs. Cr) PAT (Rs. Cr) 79.3 7.7 5.9 7.1 5.4 45.5 Q1 FY24 Q1 FY25 Q1 FY24 Q1 FY25 Q1 FY24 Q1 FY25 Geographic-Wise (%) Business-wise (%) Sales Volume (MT) 100% 100% 2,466 2,416 1% 4% Others 13% 100% 100% Inorganic Chemicals 40% Inorganic Chemicals 1,25
Slide 7: Profit & Loss Statement
Profit & Loss Statement Particulars (Rs. Crs) Q1 FY25 Q1 FY24 Y-o-Y FY24 Revenue from Operations 45.5 79.3 -42.6% 267.1 Cost of Goods Sold 26.1 59.9 188.9 Employee Cost 4.7 4.0 18 Other Expenses 7.6 7.7 33.3 EBITDA 7.1 7.7 -7.8% 26.9 EBITDA Margin 15.6% 9.7% 10.1% Other Income 3.8 3.6 13.2 Depreciat
Slide 8: Company Overview
> ae ( om a5 Eo rod UO O
Slide 9: Company Snapshot
Company Snapshot Incorporated in 1988 Only Manufacturer of HMDS in India Manufacturer of Speciality Chemicals 3rd Largest Manufacturer of HMDS Worldwide An ISO 9001:2015 and ISO 14001:2015 Certified Company Largest Manufacturer of CMIC worldwide Business Verticals: Organic Chemicals and Inorganic Ch
Slide 10: Evolution
Evolution FY89 FY95-98 FY01-03 FY05 FY14 FY15-16 » Company was » First sale of few » Commenced HMDS » First export shipment of » First sale of CMIC » First sale of Calcium incorporated as chemical products Business in 2001 HMDS Bromide (Solution) Gujarat Quinone • Pyridine Private Limited Hydrobromi
Slide 11: Global Market Presence
Global Market Presence Global Presence Key Countries » United States of » Japan America » United Arab FY24 Export Contribution*: » Italy Emirates ~41% » South Korea » Germany » Russia » Spain » People’s Republic of » Thailand China » Malaysia Over Two Decades of • Manufacturing Well Equipped to Seiz
Slide 12: Entry Barriers
Entry Barriers Complex Chemistry Stringent Impurity Measure » The involvement of complex chemistry in » Our processes and products are subject to, and the manufacture of the Products, which is measured against, high quality standards and difficult to commercialize on a large scale stringent impurity
Slide 13: Key Long-Term Relationships
Key Long-Term Relationships Organic Chemicals Inorganic Chemicals Shree Radha CC Gran Limited Overseas Liability Company Longstanding New Product New Customer Strong Base Clients Development Reach Major customers Leading to increase Few customers age Well equipped to Top 5 customers Top 10 customers
Slide 14: Moving up the Value Chain
Moving up the Value Chain Commenced Bromobenzene business in FY15 Revenue FY24 Revenue 2023 Business Rs 267 Crs Rs 64 Crs Commenced Bromide business in 2015 Organic Rs 46 Crs Rs 154 Crs Chemicals Commenced CMIC business in 2014 Inorganic Rs 13 Crs Rs 106 Crs Chemicals Commenced HMDS business in 2001
Slide 15: Key Certifications
Key Certifications Key Certificates R&D Environment In-house laboratory to test Complying All Environment Laws » Raw materials procured » The Environment (Protection) Act, 1986 » New Products & Innovation » Water Prevention and Control of Pollution Act » Final products testing at the various stages
Slide 16: Product Overview
Product Overview
Slide 17: Product Portfolio
Product Portfolio Organic Chemicals Inorganic Chemicals HMDS CMIC Bromobenzene Bromides HMDS ▪ HMDS, an organosilicon ▪ CMIC is an antiviral drug ▪ Bromobenzene, is a clear, ▪ Oilwell Completion Chemicals compound, is a reagent and a intermediate product, which is a colourless or pale-yellow liquid.
Slide 18: Manufacturing Facilities
Manufacturing Facilities Located at Manjusar near Installed Capacity Vadodara, Gujarat Sr No Product categories Key Products (MTPA) 9 Operational Plants 1 HMDS, CMIC, Bromobenzene and other ancillary products 10,800 2 Proposed Expansion Plant 2 Organic Chemicals Proposed P-10 Capacity H2FY25e under
Slide 19: Located at Manjusar near Vadodara, Gujarat
Located at Manjusar near Vadodara, Gujarat 18
Slide 20: Growth Drivers
Growth Drivers Capacity Expansion Import Substitution » We plan to add additional manufacturing capacity P10 unit and P11 unit by H2FY25. » Aims to capitalize on the potential growth of Organic Chemicals in India and to These additional capacity will manufacture organic chemicals substitute imports
Slide 21: Way Forward
Way Forward Healthy Growth in Exploring Moderate Growth in Opportunities in Organic Chemicals Inorganic Chemicals New Products Leading to Long Term Sustainable Growth New Products, New Clients, New Applications, New Opportunities 20
Slide 22: Financial Highlights
Financial Highlights
Slide 23: Financial Trends
Financial Trends Total Revenue (Rs. Cr) EBITDA (Rs. Cr) PAT (Rs. Cr) 302.9 81.1 81.6 62.8 262.1 257.1 267.1 70.3 70.7 56.4 55.1 243.5 48.9 26.9 19.2 FY20 FY21 FY22 FY23 FY24 FY20 FY21 FY22 FY23 FY24 FY20 FY21 FY22 FY23 FY24 Geographic-Wise (%) Business-wise (%) Sales Volume (MT) Others Inorganic Org
Slide 24: Key Ratios
Key Ratios Fixed Asset Debt/ equity (x) Turnover(x) 0.31 5.5 3.7 3.2 0.15 2.1 0.09 0.09 1.8 0.01 FY20 FY21 FY22 FY23 FY24 FY20 FY21 FY22 FY23 FY24 ROCE (%) ROE (%) 35% 34% 21% 19% 15% 16% 15% 12% 6% 4% FY20 FY21 FY22 FY23 FY24 FY20 FY21 FY22 FY23 FY24 23
Slide 25: Balance Sheet
Balance Sheet ASSETS (Rs. Crs) Mar-24 Mar-23 EQUITY AND LIABILITIES Mar-24 Mar-23 Non-Current Assets EQUITY AND LIABILITIES Equity a) Property, Plant And Equipment 146.5 141.4 a) Equity Share Capital 36.6 36.6 b) Capital Work in Progress 42.4 13.6 b) Other Equity 439.8 420.7 c) Right Of Use Asset 0.
Slide 26: Cash Flow Statement
Cash Flow Statement Particulars (Rs. Crs.) Mar-24 Mar-23 Net Profit Before Tax 26.3 74.2 Adjustments for: Non Cash Items / Other Investment or Financial Items 1.4 -0.8 Operating profit before working capital changes 27.7 73.3 Changes in working capital -6.7 -38.5 Cash generated from Operations 21.0
Slide 27: Thank You
Thank You Chemcon Speciality Chemicals Ltd. CIN – L24231GJ1988PLC011652 Mr. Rajesh Gandhi - CFO Email – rajesh@cscpl.com www.cscpl.com http://www.sgapl.net/images/sgapl_logo.jpg Strategic Growth Advisors Pvt. Ltd. CIN - U74140MH2010PTC204285 Mr. Shrikant Sangani / Ms. Shaily Patwa Email - shrikant.s
Chemcon Speciality Chemicals — Investor Presentation (August 2024) on 6ix